17 PATIENT COUNSELING INFORMATION
Central Nervous System (CNS) Adverse Reactions
Advise elderly patients and those with moderate and severe renal impairment of the risk of CNS adverse reactions, including confusion, delirium, hallucinations, disorientation, agitation, seizures, and lethargy
[see
Warnings and Precautions (5.1)]
. Report symptoms immediately to a healthcare provider.
QT Prolongation
Advise patients with moderate and severe renal impairment of the risk of QT interval prolongation
[see
Use in Specific Populations (8.6)]
. Report new cardiac symptoms, such as palpitations, fainting and dizziness or lightheadedness immediately to a healthcare provider.
Administration
Advise patients:
- Take famotidine tablets once daily before bedtime or twice daily in the morning and before bedtime, as recommended.
- Famotidine tablets may be taken with or without food.
- Famotidine tablets may be given with antacids.
Manufactured by:
Celltrion Pharm, Inc
82, 2sandan-ro, Ochang-eup,
Cheongwon-gu, Cheongju-si,
Chungcheongbuk-do, 28117,
Republic of Korea
Manufactured for:
Chartwell RX, LLC.
Congers, NY 10920
Revised 12/2023
L71839
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Famotidine Tablets, USP — NDC 62135-807-90 — 20 mg — 90s — Bottle Label
Famotidine Tablets, USP — NDC 62135-808-90 — 40 mg — 90s — Bottle Label
FAMOTIDINE famotidine tablet, film coated |
|
|
|
|
|
|
|
FAMOTIDINE famotidine tablet, film coated |
|
|
|
|
|
|
|
Revised: 12/2023 Chartwell RX, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/famotidine-74/page/6/